Diagnostics
Utilising interdisciplinary approaches to identify novel molecular disease markers and therapies
![multi pipette research of cancer stem cells](https://d3bpgcke55gfwt.cloudfront.net/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMzhaQVE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--514c5c2acb899cad69fd361a167d8b1f633e2fe8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdDRG9MWm05eWJXRjBTU0lJYW5CbkJqb0dSVlE2RkhKbGMybDZaVjkwYjE5c2FXMXBkRnNIYVFKWUFta0NMQUU2Q25OaGRtVnlld2s2RTNOMVluTmhiWEJzWlY5dGIyUmxTU0lIYjI0R093WlVPZ3B6ZEhKcGNGUTZEbWx1ZEdWeWJHRmpaVlE2REhGMVlXeHBkSGxwVUE9PSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--42754237235ba1e6f9325deaf83c5a2657141cd3/261331172.jpg)
Our diagnostics cross-cutting research theme brings together laboratory scientists, clinicians and technical, statistical, and database expertise to:
Technologies and methods utilised include genomics, proteomics, next generation sequencing (NGS), mass spectrometry, medical imaging (CT), graphene biosensors, database development, management, analysis and integration and statistical analysis.
The cross-cutting diagnostics theme encompasses: